Abbott's TriClip Transcatheter Tricuspid Valve Repair System Receives FDA Approval

Gelonghui April 2 | Abbott announced on Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's TriClip transcatheter tricuspid valve repair system. This approval follows the recommendation of a panel from the FDA’s Medical Device Advisory Committee, which voted 13 to 1 that the benefits of TriClip outweigh its risks.